This is a rare problem that can happen during surgery. It means tiny pieces of cancer cells might get left behind on surgical tools or equipment. If these cells are then used to operate on someone else, they can grow into a new tumor in that person.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Tumor seeding happens when cancer cells are carried out of a tumor during a medical procedure and settle somewhere new, where they can later grow into another tumor. The path is usually the one the procedure created: the track left by a biopsy needle, a keyhole surgery opening (port site), a surgical incision, a chest drain or a feeding tube site. Doctors also call it needle tract seeding, port-site metastasis or procedure-tract metastasis. Seeding is a recognized but uncommon complication. It matters because a new tumor in the skin, muscle or lining of the abdomen or chest is a return of the original cancer in a new place, and it can change treatment plans. It is different from the usual way cancer spreads, through the blood or lymph system, and different from a local recurrence, where cancer regrows from cells left behind at the original site. In practice the two can be hard to tell apart.
Seeding requires a procedure that passes through or handles a tumor. As a needle is pulled back out, it can drag a few cancer cells along its path, and tumor handling during surgery can shed cells into a wound or into the abdomen. In published reports, needle biopsies and laparoscopic (keyhole) surgery are the procedures most often involved, and carcinomas, cancers that start in the lining tissues of organs, are the tumor type most often involved. Other well-described settings include liver cancer biopsy or ablation, chest procedures in pleural mesothelioma (a cancer of the lining around the lungs) and feeding tube placement in people with head and neck cancer. How often seeding happens depends heavily on the cancer and the procedure. A 2024 analysis of liver biopsies estimated the risk at about 1 in 100. For other tumors, such as gastrointestinal stromal tumors (GIST) and most sarcomas, seeding after biopsy has been reported only rarely. Most displaced cells do not survive, which is one reason seeding is uncommon even though cells are often moved during a biopsy. Seeding is not caused by unsterile instruments; sterilization prevents infection, not cell spread. Teams reduce the risk through technique, for example using different instruments when tissue is removed from more than one area, sampling through a single protective outer needle, and planning a biopsy path that a surgeon can later remove along with the tumor.
Seeding usually shows up as a new lump in or under the skin near a scar, a biopsy site, a drain or a feeding tube site, or as a new deposit seen on a follow-up scan. The lump is often painless. It can appear months to many years after the original procedure, most often after six months. To confirm it, doctors use imaging such as ultrasound, a CT scan (detailed cross-sectional X-ray images) or an MRI scan (magnetic resonance imaging) to see the size and depth of the deposit and to check whether the cancer has spread elsewhere. A biopsy or removal of the lump shows under the microscope whether the cells match the original cancer. Because seeding and other forms of recurrence can look alike, the team considers the whole history, including where the original tumor was and which procedures were done.
A seeded tumor is treated as a return of the original cancer, so the plan depends on the type of cancer, whether it has spread elsewhere and the person's overall treatment goals. When the deposit is a single, accessible lump, surgical removal is often the main option. Radiotherapy to the area is another option, particularly when surgery is not practical. When the cancer is also present elsewhere, the seeded lump is usually managed as part of the broader cancer treatment. Prevention gets more attention than treatment. For some cancers, specialists avoid biopsy when imaging and blood tests can establish the diagnosis, which is common for some liver cancers. For others, such as suspected sarcoma, a carefully planned core needle biopsy is preferred because the information it provides guides treatment; reviews conclude that for these tumors the benefits of biopsy outweigh the small risk of seeding. Some preventive measures are less clearly useful than they sound. In pleural mesothelioma, a randomized trial found that routine radiotherapy to procedure sites did not significantly reduce tract tumors compared with treating a tumor only if one appeared. For someone who needs a biopsy, the practical point is that an accurate diagnosis usually matters far more than the small risk of seeding. Concerns are worth raising with the team so they can explain why a procedure is recommended and how they plan it.
Most people who have a cancer biopsy or surgery never develop seeding. When it does happen, it is usually found during routine follow-up or because the person notices a lump near an old scar, sometimes years later. What it means for the future depends mainly on the underlying cancer: a single deposit that can be removed completely may have little effect on the overall outlook, while seeding alongside spread elsewhere is managed as advanced disease. After treatment of a seeded deposit, follow-up usually includes regular examinations of the area and scans on the schedule set for the original cancer. Knowing where earlier procedures were done helps both the person and the team notice changes at those sites.
If you have had cancer, or a procedure on a possible cancer, tell your cancer care team about any new lump, thickening or nodule at or near a biopsy site, surgical scar, drain site or feeding tube site, even if it is painless and even if the procedure was years ago. It does not usually need emergency care, but it does need to be examined and, often, imaged. If you are worried about seeding before a planned biopsy or operation, raise it before the procedure rather than delaying a recommended test.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Tumor Seeding is like, what's helped you, or ask the community a question.